RL Siegel, KD Miller, A Jemal. Cancer statistics, 2019 (US statistics). CA Cancer J Clin 2019;69:7-34.

D Longley, P Johnston. Molecular mechanisms of drug resistance. J Pathol 2005;205:275-292.

P Wang, HL Yang, YJ Yang, et al. Overcome cancer cell drug resistance using natural products. Evid Based Complement Alternat Med 2015;2015:767136.

H Zhao, H Xie, J Li, et al. Research progress on reversing multidrug resistance in tumors by using Chinese medicine. Chin J Integr Med 2018;24:474-480.

P Joshi, RA Vishwakarma, SB Bharate. Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer. Eur J Med Chem 2017;138:273-292.

T Eichhorn, T Efferth. P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs. J Ethnopharmacol 2012;141:557-570.

C Holohan, DBL Sandra Van Schaeybroeck, PG Johnston. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 2013;13:714-726.

ST Taylor, JA Hickman, C Dive. Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors. J Natl Cancer Inst 2000;92:18-23.

MM Gottesman, T Fojo, SE Bates. Multidrug resistance in cancer:role of ATP-dependent transporters. Nat Rev Cancer 2002;2:48-58.

CH Choi. ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int 2005;5:30.

T Nakahara, T Sakaeda, T Nakamura, et al. chemosensitivity assessed by collagen gel droplet embedded culture drug sensitivity test, and MDR1, MRP1, and MRP2 mRNA expression in human colorectal adenocarcinomas. Pharm Res 2004;21:406-412.

D Cao, S Qin, Y Mu, et al. The role of MRP1 in the multidrug resistance of colorectal cancer. Oncol Lett 2017;13:2471-2476.

DL Nielsen, JA Palshof, N Brünner, et al. Implications of ABCG2 expression on irinotecan treatment of colorectal cancer patients: a review. Int J Mol Sci 2017;18:1926.

S Pratt, RL Shepard, RA Kandasamy, et al. The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites. Mol Cancer Ther 2005;4:855-863.

E Martinez-Balibrea, A Martínez-Cardús, E Musulén, et al.Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy. Int J Cancer 2009;124:2905-2910.

L Ekblad, J Kjellström, A Johnsson. Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells. Anticancer Drugs 2010;21:523-531.

H Cui, AJ Zhang, M Chen, et al. ABC transporter inhibitors in reversing multidrug resistance to chemotherapy. Curr Drug Targets 2015;16:1356-1371.

M Talekar, Q Ouyang, MS Goldberg, et al. Cosilencing of PKM-2 and MDR-1 sensitizes multidrug-resistant ovarian cancer cells to paclitaxel in a murine model of ovarian cancer. Mol Cancer Ther 2015;14:1521-1531.

MS Greenblatt, WP Bennett, M Hollstein, et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-4878.

ER Fearon, B Vogelstein. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-767.

J Boyer, EG McLean, S Aroori, et al. Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan. Clin Cancer Res 2004;10:2158-2167.

F Bunz, PM Hwang, C Torrance, et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest 1999;104:263-269.

Y Liu, L Wang, X Lu. A new way to target p53-defective colorectal cancer. Futur Oncol 2015;11:3101-3104.

S Fulda. Tumor resistance to apoptosis. Int J Cancer 2009;124:511-515.

E White. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 2012;12:401-410.

K Sasaki, NH Tsuno, E Sunami, et al. Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells. BMC Cancer 2010;10:370.

M Ayadi, A Bouygues, D Ouaret, et al. Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors. Oncotarget 2015;6:18518-18533.

P Dalerba, SJ Dylla, IK Park, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci 2007;104:10158-10163.

EH Huang, MJ Hynes, T Zhang, et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 2009;69:3382-3389.

E Martinez-Balibrea, A Martínez-Cardús, A Ginés, et al. Tumor-related molecular mechanisms of oxaliplatin resistance. Mol Cancer Ther 2015;14:1767-1776.

AD Lewis, LM Forrester, JD Hayes, et al. Glutathione S-transferase isoenzymes in human tumours and tumour derived cell lines. Br J Cancer 1989;60:327-331.

PG Johnston, HJ Lenz, CG Leichman, et al. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors.Cancer Res 1995;55:1407-1412.

Y Sugimoto, S Tsukahara, T Ohhara, et al. Decreased expression of DNA topoisomerase Ⅰ in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody. Cancer Res 1990;50:6925-6930.

K Kirschner, DW Melton. Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs.Anticancer Res 2010;30:3223-3232.

BC Fuchs, T Fujii, JD Dorfman, et al. Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Res 2008;68:2391-2399.

A Shen, H Chen, Y Chen, et al. Pien Tze Huang overcomes multidrug resistance and epithelial-mesenchymal transition in human colorectal carcinoma cells via suppression of TGF-β pathway. Evid Based Complement Alternat Med 2014;2014:679436.

RA Kumar, K Sridevi, NV Kumar, et al. Anticancer and immunostimulatory compounds from Andrographis paniculata. J Ethnopharmacol 2004;92:291-295.

GY Lee, JY Joung, JH Cho, et al. Overcoming P-glycoprotein-mediated multidrug resistance in colorectal cancer: potential reversal agents among herbal medicines. Evid Based Complement Alternat Med 2018;12:3412074.

Y Han, LM Bu, X Ji, et al. Modulation of multidrug resistance by andrographolid in a HCT-8/5-FU multidrug-resistant colorectal cancer cell line. Chin J Dig Dis 2005;6:82-86.

W Wang, W Guo, L Li, et al. Andrographolide reversed 5-FU resistance in human colorectal cancer by elevating BAX expression.Biochem Pharmacol 2016;121:8-17.

J Wang, C Chen, S Wang, et al. Bufalin inhibits HCT116 colon cancer cells and its orthotopic xenograft tumor in mice model through genes related to apoptotic and PTEN/AKT pathways.Gastroenterol Res Pract 2015;2015:1-10.

Y Qiu, Q Hu, Q Tang, et al. MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis. Tumor Biol 2014;35:2599-2606.

T Liu, T Jia, X Yuan, et al. Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancerin vitro and in vivo. Int J Nanomed 2016;11:2235-2250.

SH Wu, DT Bau, YT Hsiao, et al. Bufalin induces apoptosis in vitro and has antitumor activity against human lung cancer xenografts in vivo. Environ Toxicol 2017;32:1305-1317.

ZT Yuan, XJ Shi, YX Yuan, et al. Bufalin reverses ABCB1-mediated drug resistance in colorectal cancer. Oncotarget 2017;8:48012-48026.

J Sun, K Xu, Y Qiu, et al. Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells. Oncol Rep 2017;38:1420-1430.

Z Yuan, X Shi, Y Qiu, et al. Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin. Oncol Rep 2017;37:1815-1825.

M Gu, G Zhang, Z Su, et al. Identification of major active constituents in the fingerprint of Salvia miltiorrhiza Bunge developed by high-speed counter-current chromatography. J Chromatogr A 2004;1041:239-243.

J Zhang, M Huang, S Guan, et al. A mechanistic study of the intestinal absorption of cryptotanshinone, the major active constituent of Salvia miltiorrhiza. J Pharmacol Exp Ther 2006;317:1285-1294.

T Hu, KKW To, L Wang, et al. Reversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza.Phytomedicine 2014;21:1264-1272.

T Hu, L Wang, L Zhang, et al. Sensitivity of apoptosis-resistant colon cancer cells to tanshinones is mediated by autophagic cell death and p53-independent cytotoxicity. Phytomedicine 2015;22:536-544.

Z Xu, H Jiang, Y Zhu, et al. Cryptotanshinone induces ROS-dependent autophagy in multidrug-resistant colon cancer cells.Chem Biol Interact 2017;273:48-55.

P Guo, S Wang, W Liang, et al. Salvianolic acid B reverses multidrug resistance in HCT-8/VCR human colorectal cancer cells by increasing ROS levels. Mol Med Rep 2017;15:724-730.

R Hanif, L Qiao, SJ Shiff, et al. Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway. J Lab Clin Med 1997;130:576-584.

DP Chauhan. Chemotherapeutic potential of curcumin for colorectal cancer. Curr Pharm Des 2002;8:1695-1706.

WD Lu, Y Qin, C Yang, et al. Effect of curcumin on human colon cancer multidrug resistance in vitro and in vivo. Clinics 2013;68:694-701.

V Ruiz De Porras, S Bystrup, A Martínez-Cardús, et al. Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/ NF-κB signalling pathway. Sci Rep 2016;6:24675.

J Nautiyal, SS Kanwar, Y Yu, et al. Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells. J Mol Signal 2011;6:7.

C Buhrmann, P Kraehe, C Lueders, et al. Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT. PLoS One 2014;9:e107514.

L Lin, Y Liu, H Li, et al. Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030. Br J Cancer 2011;105:212-220.

SS Kanwar, Y Yu, J Nautiyal, et al. Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells. Pharm Res 2011;28:827-838.

S Roy, Y Yu, SB Padhye, et al. Difluorinated-curcumin (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21. PLoS One 2013;8:e68543.

Y Zhang, Z Ning, S Yang, et al. Antioxidation properties and mechanism of action of dihydromyricetin from Ampelopsis grossedentata. Acta Pharm Sin (Chin) 2003;38:241-244.

T Chen, S Zhu, Y Lu, et al. Probing the interaction of anti-cancer agent dihydromyricetin with human serum albumin: a typical method study.Anticancer Agents Med Chem 2012;12:919-928.

S Wu, B Liu, Q Zhang, et al. Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells. PLoS One 2013;8:e76886.

Z Zhao, JQ Yin, MS Wu, et al. Dihydromyricetin activates AMP-activated protein kinase and p38MAPK exerting antitumor potential in osteosarcoma. Cancer Prev Res 2014;7:927-938.

Z Wang, X Sun, Y Feng, et al. Dihydromyricetin reverses MRP2-mediated MDR and enhances anticancer activity induced by oxaliplatin in colorectal cancer cells. Anticancer Drugs 2017;28:281-288.

Z Wang, L Zhang, Z Ni, et al. Resveratrol induces AMPK-dependent MDR1 inhibition in colorectal cancer HCT116/L-OHP cells by preventing activation of NF-κB signaling and suppressing cAMP-responsive element transcriptional activity. Tumor Biol 2015;36:9499-9510.

JT Hwang, DW Kwak, SK Lin, et al. Resveratrol induces apoptosis in chemoresistant cancer cells via modulation of AMPK signaling pathway. Ann N Y Acad Sci 2007;1095:441-448.

L Huang, S Zhang, J Zhou, et al. Effect of resveratrol on drug resistance in colon cancer chemotherapy. RSC Adv 2019;9:2572-2580.

SY Eid, MZ El-Readi, ML Ashour, et al. Fallopia japonica, a natural modulator, can overcome multidrug resistance in cancer cells. Evid Based Complement Alternat Med 2015;2015:868424.

J Wang, Z Yuan. Gambogic acid sensitizes ovarian cancer cells to doxorubicin through ROS-mediated apoptosis. Cell Biochem Biophys 2013;67:199-206.

T Wang, J Wei, X Qian, et al. Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells.Cancer Lett 2008;262:214-222.

P Yang, J Cao, MH Tan, et al. Reversal of resistance to Oxaliplatin in human colon cancer by gambogic acid. Chin Arch Gen Surg (Elect Ed, Chin) 2013;07.

Q Wang, J Wei, C Wang, et al. Gambogic acid reverses oxaliplatin resistance in colorectal cancer by increasing intracellular platinum levels. Oncol Lett 2018;16:2366-2372.

Q Li, X Wang, A Shen, et al. Hedyotis diffusa Willd overcomes 5-fluorouracil resistance in human colorectal cancer HCT-8/5-FU cells by downregulating the expression of P-glycoprotein and ATP-binding casette subfamily G member 2. Exp Ther Med 2015;10:1845-1850.

G Sun, L Wei, J Feng, et al. Inhibitory effects of Hedyotis diffusa Willd. on colorectal cancer stem cells. Oncol Lett 2016;11:3875-3881.

Y Zhang, L Huang, H Shi, et al. Ursolic acid enhances the therapeutic effects of oxaliplatin in colorectal cancer by inhibition of drug resistance. Cancer Sci 2018;109:94-102.

CPR Xavier, CF Lima, DFN Pedro, et al. Ursolic acid induces cell death and modulates autophagy through JNK pathway in apoptosis-resistant colorectal cancer cells. J Nutr Biochem 2013;24:706-712.

J Wang, L Liu, H Qiu, et al. Ursolic acid simultaneously targets multiple signaling pathways to suppress proliferation and induce apoptosis in colon cancer cells. PLoS One 2013;8:e63872.

Y Li, Y Li, X Chen, et al. Autophagy is involved in anticancer effects of matrine on SGC-7901 human gastric cancer cells. Oncol Rep 2011;26:115-124.

H Li, G Tan, X Jiang, et al. Therapeutic effects of matrine on primary and metastatic breast cancer. Am J Chin Med 2010;38:1115-1130.

H Ren, S Zhang, H Ma, et al. Matrine reduces the proliferation and invasion of colorectal cancer cells via reducing the activity of p38 signaling pathway. Acta Biochim Biophys Sin (Chin) 2014;46:1049-1055.

C Chang, SP Liu, CH Fang, et al. Effects of matrine on the proliferation of HT29 human colon cancer cells and its antitumor mechanism. Oncol Lett 2013;6:699-704.

L Duan, L Deng, D Wang, et al. Treatment mechanism of matrine in combination with irinotecan for colon cancer. Oncol Lett 2017;14:2300.

D Zhang, Y Zhang. The Reversal effects of matrine on the multi-drug resistance of oxaliplatin in human colon HT-29 cells and its mechanism research. J Hunan Univ Chin Med (Chin) 2016;36:22-26.

J Su, Q Jiang, G Huang, et al. Effect of matrine on chemotherapeutic drug sensitivity and autophagy levels in colon cancer resistant cells.Chin Youjiang Med J (Chin) 2016;44:610-613.

ZQ Zhong, GL Huang, ZS Huang, et al. Oxymartrine reverses multidrug resistance of human colon cancer cell lines and its mechanism. J Youjiang Med Coll Natl (Chin) 2017;39:17-21.

X Feng, L Li, H Jiang, et al. Dihydroartemisinin potentiates the anticancer effect of cisplatin via mTOR inhibition in cisplatin-resistant ovarian cancer cells: involvement of apoptosis and autophagy. Biochem Biophys Res Commun 2014;444:376-381.

XJ Kang, HY Wang, HG Peng, cet al. Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy. Acta Pharmacol Sin 2017;38:885-896.

G Ma, L Chong, XC Li, et al. Selective inhibition of human leukemia cell growth and induction of cell cycle arrest and apoptosis by pseudolaric acid B. J Cancer Res Clin Oncol 2010;136:1333-1340.

F Yu, K Li, S Chen, et al. Pseudolaric acid B circumvents multidrug resistance phenotype in human gastric cancer SGC7901/ADR cells by downregulating cox-2 and p-gp expression. Cell Biochem Biophys 2015;71:119-126.

VK Wong, P Chiu, SS Chung, et al. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo. Clin Cancer Res 2005;11:6002-6011.

C Wen, J Chen, D Zhang, et al. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells. Cancer Lett 2016;383:295-308.

J Liu, W Guo, B Xu, et al. Angiogenesis inhibition and cell cycle arrest induced by treatment with pseudolarix acid B alone or combined with 5-fluorouracil. Acta Biochim Biophys Sin (Chin)2012;44:490-502.

MP Liu, M Liao, C Dai, et al. Sanguisorba officinalis L synergistically enhanced 5-fluorouracil cytotoxicity in colorectal cancer cells by promoting a reactive oxygen species-mediated, mitochondria-caspase-dependent apoptotic pathway. Sci Rep 2016;6:34245.

CZ Wang, E McEntee, S Wicks, et al. Phytochemical and analytical studies of Panax notoginseng (Burk.) F.H. Chen. J Nat Med 2006;60:97-106.

Y Zheng, H Nan, M Hao, et al. Antiproliferative effects of protopanaxadiol ginsenosides on human colorectal cancer cells.Biomed reports 2013;1:555-558.

LTH Phi, YT Wijaya, IN Sari, et al. The anti-metastatic effect of ginsenoside Rb2 in colorectal cancer in an EGFR/SOX2-dependent manner. Cancer Med 2018;7:5621-5631.

G Liu, Y Liu, G Jiang, et al. The reversal effect of Ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanism. Hum Cell 2018;31:189-198.

HB Li, F Chen. Isolation and purification of baicalein, wogonin and oroxylin A from the medicinal plant Scutellaria baicalensis by high-speed counter-current chromatography. J Chromatogr A 2005;1074:107-110.

DH Kim, MA Hossain, YJ Kang, et al. Baicalein, an active component of Scutellaria baicalensis Georgi, induces apoptosis in human colon cancer cells and prevents AOM/DSS-induced colon cancer in mice. Int J Oncol 2013;43:1652-1658.

DH Kim, B Sung, HY Chung, et al. Modulation of colitis-associated colon tumorigenesis by baicalein and betaine. J Cancer Prev 2014;19:153-160.

Y Tao, S Zhan, Y Wang, et al. Baicalin, the major component of traditional Chinese medicine Scutellaria baicalensis induces colon cancer cell apoptosis through inhibition of oncomiRNAs. Sci Rep 2018;8:14477.

H Wang, L Zhao, LT Zhu, et al. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.Mol Carcinog 2014;53:E107-E118.

J Gao, W Yin, O Corcoran. From Scutellaria barbata to BZL101 in cancer patients: phytochemistry, pharmacology, and clinical evidence. Nat Prod Commun 2019;14:1-12.

J Lin, J Feng, H Yang, et al. Scutellaria barbata D. Don inhibits 5-fluorouracil resistance in colorectal cancer by regulating PI3K/AKT pathway. Oncol Rep 2017;38:2293-2300.

SB Syed, H Arya, IH Fu, et al. Targeting P-glycoprotein:Investigation of piperine analogs for overcoming drug resistance in cancer. Sci Rep 2017;7:7972.

LM Guamán Ortiz, AL Croce, F Aredia, et al. Effect of new berberine derivatives on colon cancer cells. Acta Biochim Biophys Sin (Chin)2015;47:824-833.

Y Zhang, X Sun, J Xu, et al. Effects of medicated serum prepared with Chinese herbal medicine Changweiqing on pharmacokinetics of oxaliplatin in colon cancer cells. J Chin Integr Med (Chin)2012;10:901-910.

J Xu, W Deng, Z Fan. Effects of changwelqing on nuclear translocation of Y-box binding protein-1 and expression of P-glycoprotein in human colon cancer cell line with drug-resistance induced by vincristine. Chin J Integr Tradit West Med (Chin) 2010;30:743-747.

J Li, Z Fan, J Sun, et al. In vitro antimetastatic effect of Changweiqing through antiinvasion of hypoxic colorectal carcinoma LoVo cells. Chin J Integr Med 2011;17:517-524.

H Sui, H Zhu, J Wu, et al. Effects of Jianpi Jiedu Recipe on reversion of P-glycoprotein-mediated multidrug resistance through COX-2 pathway in colorectal cancer. Chin J Integr Med 2014;20:610-617.

X Liu, Q Ji, W Deng, et al. Jianpi Jiedu Recipe inhibits epithelial-to-mesenchymal transition in colorectal cancer through TGF-β/Smad mediated snail/E-cadherin expression. Biomed Res Int 2017;2017:2613198.

J Lin, L Wei, Y Chen, et al. Pien Tze Huang-induced apoptosis in human colon cancer HT-29 cells is associated with regulation of the Bcl-2 family and activation of caspase 3. Chin J Integr Med 2011;17:685-690.

Q Zhuang, F Hong, A Shen, et al. Pien Tze Huang inhibits tumor cell proliferation and promotes apoptosis via suppressing the STAT3 pathway in a colorectal cancer mouse model. Int J Oncol 2012;40:1569-1574.

AL Shen, F Hong, LY Liu, et al. Effects of Pien Tze Huang on angiogenesis in vivo and in vitro. Chin J Integr Med 2012;18:431-436.

A Shen, F Hong, L Liu, et al. Pien Tze Huang inhibits the proliferation of human colon carcinoma cells by arresting G1/S cell cycle progression. Oncol Lett 2012;4:767-770.

L Wei, P Chen, Y Chen, et al. Pien Tze Huang suppresses the stem-like side population in colorectal cancer cells. Mol Med Rep 2014;9:261-266.

A Sun, JS Chia, CP Chiang, et al. The Chinese herbal medicine Tien-Hsien Liquid inhibits cell growth and induces apoptosis in a wide variety of human cancer cells. J Altern Complement Med 2005;11:245-256.

SC Sze, KL Wong, WK Liu, et al. Regulation of p21, MMP-1, and MDR-1 expression in human colon carcinoma HT29 cells by Tian Xian Liquid, a Chinese medicinal formula, in vitro and in vivo. Integr Cancer Ther 2011;10:58-69.

H Sui, P Duan, P Guo, et al. Zhi Zhen Fang formula reverses Hedgehog pathway mediated multidrug resistance in colorectal cancer. Oncol Rep 2017;38:2087-2095.

S Cai, X Zhang, Z Chen, et al. Medicated serum prepared with Chinese herbal medicine Zhizhen Recipe down-regulates activity of nuclear factor-κB and expression of P-glycoprotein in human colorectal cancer multidrug-resistant cell line HCT-8/VCR. J Chin Integr Med (Chin) 2011;9:1353-1359.

X Wang, L Xu, J Peng. In vivo inhibition of S180 tumors by the synergistic effect of the Chinese medicinal herbs Coptis chinensis and Evodia rutaecarpa. Planta Med 2009;75:1215-1220.

H Sui, X Liu, BH Jin, et al. Zuo Jin Wan, a traditional chinese herbal formula, reverses P-gp-mediated MDR in vitro and in vivo. Evid Based Complement Alternat Med 2013;2013:265-269.

C Yu, SL Liu, MH Qi, et al. Herbal medicine Guan Chang Fu Fang enhances 5-fluorouracil cytotoxicity and affects drug-associated genes in human colorectal carcinoma cells. Oncol Lett 2015;9:701-708.

SH Liu, YC Cheng. Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy. J Ethnopharmacol 2012;140:614-623.

H Liu, H Liu, Z Zhou, et al. Herbal formula Huang Qin Ge Gen Tang enhances 5-fluorouracil antitumor activity through modulation of the E2F1/TS pathway. Cell Commun Signal 2018;16:7.

D Chattopadhyay, SR Dungdung, AB Mandal, et al. A potent sperm motility-inhibiting activity of bioflavonoids from an ethnomedicine of Onge, Alstonia macrophylla Wall ex A. DC, leaf extract.Contraception 2005;71:372-378.

B Messner, I Zeller, C Ploner, et al. Ursolic acid causes DNA-damage, P53-mediated, mitochondria- and caspase-dependent human endothelial cell apoptosis, and accelerates atherosclerotic plaque formation in vivo. Atherosclerosis 2011;219:402-408.

XY Xu, X Meng, S Li, et al. Bioactivity, health benefits, and related molecular mechanisms of curcumin: current progress, challenges, and perspectives. Nutrients 2018;10:1553.

AK Yang, SM He, L Liu, et al. Herbal Interactions with anticancer drugs: mechanistic and clinical considerations. Curr Med Chem 2010;17:1635-1678.

Y Zhang, J Wang. MicroRNAs are important regulators of drug resistance in colorectal cancer. Biol Chem 2017;398:929-938.

QB Wu, X Sheng, N Zhang, et al. Role of microRNAs in the resistance of colorectal cancer to chemoradiotherapy. Mol Clin Oncol 2018;8:528.

J Tintelnot, A Stein. Immunotherapy in colorectal cancer: available clinical evidence, challenges and novel approaches. World J Gastroenterol 2019;25:3920-3928.

DVF Tauriello, S Palomo-Ponce, D Stork, et al. TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis. Nature 2018;554:538-543.